PDLLA + HA
Juvelook is a hybrid filler which have connected both benefits of immediate filling effect of HA (hyaluronic acid) and long-term stimulation of collagen production by PDLLA (Poly D,L – lactide).
Thanks to the combination of PDLLA polylactic acid with HA hyaluronic acid, we obtain an effect that is visible immediately after the treatment. The filling is maintained until the production of new collagen, elastin, by polylactic acid begins to dominate.
Made in Korea
Features of Juvelook
-
the only hybrid formula in the world Poly D, L Lactide + HA with particle size from 10 to 40 micrometers
-
effectiveness and safety confirmed by clinical trials
-
durability of effects – over 2 years from the last treatment
-
immediate effect – due to hyaluronic acid
-
safety – FDA and CE certificates for polylactic acid
-
patents and own clinical trials
-
particle size from 10 to 40 microns
-
comfort of the procedure – easy injection and no needle clogging during the procedure
Dark under eyes
Juvelook is a great tool to treat volume loss and color discolorations
Suggested number of treatments and vials:
1 vials per session for 2-3 sessions, with 6-8 weeks between sessions.
Clear signs of aging and lack of volume
Thanks to the combination of PDLLA polylactic acid with HA hyaluronic acid, we obtain an effect that is visible immediately after the treatment. The filling is maintained until the production of new collagen, elastin, by polylactic acid begins to dominate.
Suggested number of treatments and vials:
1 vials per session for 2-3 sessions, with 6-8 weeks between sessions.
Efficacy of PDLLA
According to the result of checking the effects of PDLLA+HA treatments on a total of 54 patients in Korea, in weeks 24 and 48 following the treatment, the treatment success rate* turned out to be 100% and 88.7%, respectively, which is very high
The treatment success rate by the period after PDLLA+HA treatment
* The rate of subjects whose WSRS(wrinkle severity rating scale) improved by 1point or
more at 24 and 48 weeks after the procedure compared to the baseline.
